Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67,833,122
-
Total 13F shares
-
75,062,169
-
Share change
-
-5,757,507
-
Total reported value
-
$911,087,579
-
Put/Call ratio
-
13%
-
Price per share
-
$12.14
-
Number of holders
-
251
-
Value change
-
-$138,652,756
-
Number of buys
-
114
-
Number of sells
-
153
Institutional Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q3 2025
As of 30 Sep 2025,
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) was held by
251 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,062,169 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Sessa Capital IM, L.P., ArrowMark Colorado Holdings LLC, GW&K Investment Management, LLC, STATE STREET CORP, Hood River Capital Management LLC, Paradice Investment Management LLC, Freestone Grove Partners LP, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
251
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.